The company ALPX was founded in 2019 in France, out of the EMBL Grenoble. It is located on the European Photon & Neutron Science Campus in close proximity to the European Synchrotron Radiation Facility. The company provides automated protein crystallography services based on EMBL’s proprietary CrystalDirect® technology and the online platform CRIMS. The services allow for a faster generation of structures which accelerates the drug discovery process.